Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Evaluation of Corneal Oedema – Tools we Have and Those Under Investigation

Yu-Chi Liu, Lin Ke, Jodhbir Singh Mehta
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Published Online: Feb 3rd 2020 European Ophthalmic Review, 2019;13(2):76–80 DOI: https://doi.org/10.17925/EOR.2019.13.2.76
Select a Section…
1

Abstract

Overview

Corneal oedema is a common sign of acute or chronic corneal disease resulting from various aetiologies such as corneal endothelial dystrophy, prior surgery such as cataract surgery, metabolic disorders, toxicity or hypoxia. Measurement of central corneal thickness (CCT) is an objective and surrogate assessment for the evaluation of corneal oedema. The commonly used tools for the CCT measurements include ultrasonic pachymetry, anterior segment optical coherence tomography, specular microscopy and corneal tomography. Terahertz and mid-infrared technology have emerged recently for their applications on corneas. Instead of measuring CCT, they detect the changes of corneal water concentrations because their light wave spectrum is sensitive to water. The utility of these imaging systems as an adjuvant tool for the evaluation of corneal oedema, will be discussed in this article.

Keywords

Corneal edema, corneal disease, corneal endothelial dystrophy, central corneal thickness, CCT, Terahertz, mid-infrared technology

2

Article Information

Disclosure

Yu-Chi Liu, Lin Ke and Jodhbir S Mehta have nothing to disclose in relation to this article.

Review Process

Double-blind peer review.

Authorship

All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship of this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval to the version to be published.

Correspondence

Yu-Chi Liu, 20 College Road, Discovery Tower, Level 12, Singapore 169856. E: liuchiy@gmail.com

Support

No funding was received in
the publication of this article.

Acknowledgements

All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship of this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval to the version to be published.

Received

25 October 2019

3

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Close Popup